Kidney donation and transplant information made easy for End-stage Renal Disease
Increasing Live Donor Kidney Transplantation Through Video-based Education and Mobile Communication
See full descriptionAbout the trial for End-stage Renal Disease
Treatment Groups
This trial involves 2 different treatments. Kidney Donation And Transplant Information Made Easy is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
Eligibility
This trial is for patients born any sex of any age. There are 4 eligibility criteria to participate in this trial as listed below.
Approximate Timelines
Measurement Requirements
This trial is evaluating whether Kidney donation and transplant information made easy will improve 1 primary outcome, 4 secondary outcomes, and 1 other outcome in patients with End-stage Renal Disease. Measurement will happen over the course of 12 months.
Who is running the study
Principal InvestigatorPatient Q & A Section
What causes end-stage renal disease?
There are many different causes, usually with many different effects. The major causes of end-stage renal disease include diabetes and hypertension (high blood pressure); glomerulonephritis may also be a contributor. It is more difficult to find a specific cause in people who have the disease. For information of a more personalized approach to treating end-stage renal disease, see: www.treatmentsforkidneydiseases.org.
How many people get end-stage renal disease a year in the United States?
Rates of ESRD may be increasing more rapidly among blacks than whites. Rates of ESRD and death due to ESRD will likely remain high in the future.
Can end-stage renal disease be cured?
ESRD is a devastating disease with a very poor prognosis. The treatment of acute kidney injury resulting from ESRD is paramount. While no curative treatment has been identified, some improvements can be made using current dialysis techniques to prolong or eliminate dialysis.
What is end-stage renal disease?
ESRD is a disease syndrome characterised by the progressive deterioration of the ability to regulate volume and osmolarity. The two major clinical manifestations of ESRD are hyperkalaemia and metabolic acidosis. Although the pathogenesis of ESRD has not been fully explained, it is likely to be multifactorial and may involve a range of aetiological mechanisms, some of which predispose to ESRD and other complications of this disease.
What are common treatments for end-stage renal disease?
No direct kidney or lung transplantation is available to people on the waiting list for a kidney. Instead, in many European cities, some patients are offered dialysis and sometimes a kidney transplant. Dialysis treatment was only available because of the existence of a national kidney registry which tracks patient survival among other data and monitors waiting times. In the United States, the situation is different and some patients are offered kidney transplantation. In the United States, some patients are offered lung transplantation. In China and Singapore dialysis and an artificial kidney is available while in Europe, lung transplantation is the preferred treatment because of the lack of dialysis facilities.
What are the signs of end-stage renal disease?
Signs of early-stage renal dysfunction may include nocturia, loss of appetite, anorexia and fatigue. As kidney function worsens, signs of electrolytes in kidney-related complications, such as volume overload and anemia are observed. When end-stage renal disease is seen with accompanying cardiovascular disease, signs include elevated serum lipid levels, edema, and loss of physical ability.\nhttps://www.researchgate.
What is the latest research for end-stage renal disease?
There is no evidence that dialysis is an effective treatment for patients who are candidates for renal transplantation. This evidence should always be considered when allocating limited healthcare resources. It should be a key consideration if patients with chronic renal failure and their doctors anticipate significant improvement in quality of life after their transplant is completed.
How does kidney donation and transplant information made easy work?
With regard to the issue of kidney donation and transplant information, education about various aspects of the donation process, and strategies to make the donation process easier was needed.
What are the common side effects of kidney donation and transplant information made easy?
Common side effects of kidney donation and [transplant](https://www.withpower.com/clinical-trials/transplant) information made easy are most commonly gastrointestinal and include nausea and vomiting, decreased appetite, abdominal pain, diarrhea, and constipation. Additional side effects are almost equally common; most often there is a temporary feeling of coldness in the legs, sweating more, shortness of breath, palpitations, anxiety, feeling of pressure in the chest, and sudden changes in blood pressure and pulse. If you become faint, lightheaded, short of breath, or have chest pain or pains in your back, neck, shoulders, or arms, see a health care provider immediately. If your heart rate drops, call your health provider immediately.
Have there been other clinical trials involving kidney donation and transplant information made easy?
For patients, clinicians, and patients wanting to participate in the [kidney transplant](https://www.withpower.com/clinical-trials/kidney-transplant)ation procedure, the results should be simple and intuitive: one-stop website and self-regulatory information on the transplant center site on which patients can get all the information they need to make informed decisions.
Does kidney donation and transplant information made easy improve quality of life for those with end-stage renal disease?
The quality of information supplied to ESRD patients of potential kidney donors was poor. This was an important contributor to poor understanding of kidney donor transplantations. Increasing information on kidney grafts and transplantation procedures could assist the patients in better understanding the procedure and potentially lead to better outcomes.
Is kidney donation and transplant information made easy safe for people?
The need of the people about to donate his/her kidney to get the best treatment in the kidney disease in a timely manner should be known. Awareness of the disease would be the best and only option to make this a safe and affordable thing.